Ximaract

Ximaract (Cefuroxime) is an antibiotic used intracamerally to prevent infections after eye surgery. It belongs to the cephalosporin class and targets bacterial growth. This sterile solution is designed for ophthalmic use only.

Ximaract is primarily used to reduce the risk of bacterial infections following cataract surgery. It works by stopping the growth of bacteria that could cause post-operative complications. The medication is administered directly into the eye during the procedure. It is not intended for systemic infections or other non-ophthalmic conditions.

After intracameral administration, Ximaract may help prevent inflammation or infection in the eye. Some patients report temporary blurred vision or mild discomfort at the injection site. These effects are usually short-lived and resolve without additional treatment.

Ximaract should only be handled and administered by a healthcare professional. It must be stored in a sterile environment and used immediately after opening. Patients with known allergies to cephalosporins or penicillins should inform their doctor before use. Always follow the prescribed procedure for intracameral injection.

No specific drug interactions are documented for intracameral use of Ximaract. However, systemic antibiotics may interact with other medications. Patients should disclose all current medications to their healthcare provider. Alcohol and certain supplements may also affect treatment outcomes.